KR101652263B1 - Adhesive Protein Comprising Antimicrobial Peptide and Antimicrobial Coating Composition Comprising the Same - Google Patents
Adhesive Protein Comprising Antimicrobial Peptide and Antimicrobial Coating Composition Comprising the Same Download PDFInfo
- Publication number
- KR101652263B1 KR101652263B1 KR1020140072353A KR20140072353A KR101652263B1 KR 101652263 B1 KR101652263 B1 KR 101652263B1 KR 1020140072353 A KR1020140072353 A KR 1020140072353A KR 20140072353 A KR20140072353 A KR 20140072353A KR 101652263 B1 KR101652263 B1 KR 101652263B1
- Authority
- KR
- South Korea
- Prior art keywords
- tyr
- lys
- gly
- antimicrobial
- pro
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
- C09J189/00—Adhesives based on proteins; Adhesives based on derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
- C09J7/00—Adhesives in the form of films or foils
- C09J7/30—Adhesives in the form of films or foils characterised by the adhesive composition
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Peptides Or Proteins (AREA)
Abstract
본 발명은 자가 접착력이 있는 접착 단백질의 말단에 항균 펩티드가 융합된 항균 접착 단백질, 상기 항균 접착 단백질을 포함하는 항균 코팅 조성물 및 상기 항균 코팅 조성물이 코팅된 항균 필름에 관한 것이다. 본 발명의 항균 접착 단백질 및 이를 포함하는 항균 코팅 조성물은 휴대폰의 액정 보호 필름, 식품 포장재, 의료기구 등의 표면에 코팅되어 유해 미생물에 대한 안정성을 확보할 수 있으며, 특히 본 발명의 항균 접착 단백질은 항균성이 지속적으로 유지됨으로써 항균 물질에 용출에 의한 항균력 감소를 방지할 수 있다.The present invention relates to an antibacterial adhesive protein in which an antibacterial peptide is fused at the end of a self-adhesive adhesive protein, an antibacterial coating composition comprising the antibacterial adhesive protein, and an antibacterial film coated with the antibacterial coating composition. The antimicrobial adhesive protein of the present invention and the antimicrobial coating composition containing the antimicrobial adhesive protein of the present invention can be coated on the surface of a liquid crystal protective film, a food packaging material, a medical instrument, etc. of a mobile phone to ensure safety against harmful microorganisms. By maintaining the antimicrobial activity constantly, it is possible to prevent the antibacterial activity from being reduced by the elution of the antimicrobial substance.
Description
본 발명은 항균 펩티드를 포함하는 접착 단백질, 상기 접착 단백질을 포함하는 항균 코팅 조성물, 상기 항균 코팅 조성물이 코팅된 항균 필름 및 코팅 방법에 관한 것이다. 보다 상세하게는, 접착 단백질의 C-말단 혹은 N-말단 혹은 하이브리드 접착 단백질 사이에 항균 펩티드가 융합된 접착 단백질 및 이를 포함하는 항균 코팅 조성물에 관한 것이다.The present invention relates to an adhesive protein comprising an antibacterial peptide, an antibacterial coating composition comprising the adhesive protein, an antibacterial film coated with the antibacterial coating composition and a coating method. More specifically, the present invention relates to an adhesive protein and an antibacterial coating composition comprising the same, wherein the antibacterial peptide is fused between the C-terminal or N-terminal or hybrid adhesive protein of the adhesive protein.
일상생활에 사용되는 전자 제품 등의 다양한 생활용품은 먼지, 지문, 타액, 기름기 등의 주변 환경으로 인해 해로운 세균이나 바이러스에 쉽게 노출된다. 더욱이 환경 위생에 대한 높은 관심과 생활 양식의 고급화에 따라 식품 포장재, 보관용 용기, 칫솔, 도마, 문구류, 화장품 및 포장재와 같은 산업용품과 의료용품으로 사용하는 석유화학 소재에 항균성을 부여한 제품들의 생산 및 수요가 증가하고 있다.A variety of daily necessities such as electronic products used in everyday life are easily exposed to harmful bacteria or viruses due to dust, fingerprints, saliva, and grease. Furthermore, due to the high interest in environmental hygiene and the upgrading of lifestyle, production of antibacterial properties of petrochemical materials used for industrial products such as food packaging materials, storage containers, toothbrushes, chopping boards, And demand is increasing.
많은 항균 조성물들이 상품화 되었으나, 대부분 항균제를 액상이나 고분자 물질에 첨가한 혼합형이었기 때문에(특허문헌 1 참조), 사용 중에 항균 성분이 서서히 제거되어 항균활성의 지속성에 문제가 제기되고 있다. 또한, 종래의 항균기술은 주로 은 나노입자나 무기입자들을 사용하는 것으로 미세 입자의 이탈로 인한 인체 유해성에 대한 논쟁이 있어 왔으며, 이에 따라 친환경적인 항균기술에 대한 요구가 증가하고 있다. 4급 암모늄염, 트라이진계, 벤즈이미다졸 등의 유기계 항균 물질 및 정유(essential oil), 고추냉이 추출물 등의 천연 항균 물질은 고분자 물질에 항균력을 부여하기 위하여 항균성 물질을 고분자 물질에 단순 첨가하여 항균성 소재를 제조하고 있으나(특허문헌 2 및 특허문헌 3), 유기계 항균물질의 자체적인 독성, 항균물질의 용출 및 그에 따른 항균력 감소 등의 기술적 한계가 지적되고 있으며(비특허문헌 1), 특히 플라스틱류를 사출 또는 압출하는 경우 항균성 물질은 열분해 및 황변 현상을 유발하기도 한다. 더욱이 항균 필름을 식품과 함께 포장하는 경우, 상기에 언급된 항균물질의 용출로 인한 내성 유발 등의 심각한 부작용이 발생할 수 있는 문제점이 제기되고 있다.Many antimicrobial compositions have been commercialized. However, since most of the antimicrobial compositions are mixed with liquid or polymeric substances (see Patent Document 1), the antimicrobial component is gradually removed during use, and the persistence of the antimicrobial activity is raised. In addition, conventional antimicrobial techniques have mainly been using silver nanoparticles or inorganic particles, and there has been controversy about human hazards due to dislocation of fine particles, and thus there is an increasing demand for environmentally friendly antibacterial technology. Organic antimicrobial substances such as quaternary ammonium salts, triazine, and benzimidazole, and natural antimicrobial substances such as essential oil and extract of horseradish have been added to the polymer substance simply by adding an antimicrobial substance to the polymer substance, (Patent Document 2 and Patent Document 3), technical limitations such as the self-toxicity of the organic antimicrobial substance, the elution of the antimicrobial substance and the reduction of the antibacterial activity thereof have been pointed out (Non-Patent Document 1) When injected or extruded, the antimicrobial material may cause pyrolysis and yellowing. Furthermore, when the antimicrobial film is packaged together with the food, a serious side effect such as causing tolerance due to elution of the antimicrobial substance mentioned above may occur.
이에 따라 항균제를 고정화하거나, 물질의 화학적 구조가 균을 사멸시키거나, 균이 표면에 부착되지 못하게 하는 물질을 항균제로 개발하여 항균 지속성을 높이는 방법들이 연구되고 있다(특허문헌 4, 비특허문헌 2 및 비특허문헌 3). 또한, 광범위한 항균력을 부여하기 위해 2개 이상의 항균제가 포함되는 항균 기술들이 개발되고 있다(특허문헌 5).Methods for immobilizing the antimicrobial agent or increasing the antimicrobial persistence by developing a substance that prevents the chemical structure of the substance from killing the bacteria or preventing the bacteria from adhering to the surface have been studied (Patent Document 4, Non-Patent Document 2 And non-patent document 3). In addition, antimicrobial techniques including two or more antimicrobial agents have been developed to give a broad antibacterial power (Patent Document 5).
이에, 본 발명은 순수한 단백질로 구성되고 본질적으로 접착력을 갖는 동시에 다양한 미생물에 항균 효과를 갖는 수용성 코팅 조성물을 제공하며, 본 발명에 의한 항균 조성물은 기존 기술에 비해 강력한 항균력은 물론 가공성과 특정 조건하에서의 생분해성이 뛰어나고, 유기용매를 사용하지 않는 친환경성이 우수한 특성이 있다.Accordingly, the present invention provides a water-soluble coating composition composed of a pure protein and having an adhesive strength, and having an antibacterial effect on various microorganisms. The antimicrobial composition according to the present invention has a strong antibacterial activity, It has excellent biodegradability and excellent environment-friendliness without using an organic solvent.
본 발명은 상기와 같은 문제점을 해결하기 위하여 도출된 것으로서, 다양한 표면에 대한 우수한 코팅력을 갖는 접착 단백질의 C-말단 혹은 N-말단에 항균 펩티드가 융합된 접착 단백질 및 이를 포함하는 항균 코팅 조성물을 제공하는 것을 목적으로 한다.Disclosure of the Invention The present invention has been made to solve the above-mentioned problems, and it is an object of the present invention to provide an antibacterial coating composition comprising the adhesive protein in which the antibacterial peptide is fused to the C- The purpose is to provide.
또한, 본 발명은 접착 단백질의 티로신 잔기를 DOPA(3,4-dihydroxyphenylalanine)로 화학적 수정(modification)함으로써 간단한 방법으로 항균 표면 코팅이 가능하고, 수용성 코팅 조성물로 유기용매의 사용없이 가혹한 조건에서 오랜 시간 동안 코팅의 지속이 가능한 환경 친화형 코팅 조성물을 제공하는 것을 목적으로 한다.The present invention also relates to a method for chemically modifying tyrosine residues of an adhesive protein with 3,4-dihydroxyphenylalanine (DOPA), which can be coated with an antimicrobial surface by a simple method, The present invention also provides an environmentally friendly coating composition capable of sustaining a coating for a long period of time.
또한, 본 발명은 광경화형 우레탄 아크릴레이트와 항균 펩티드 융합 접착 단백질의 혼합을 통해 액정 필름 등의 다양한 소재에 적용할 수 있는 광경화형 항균 코팅 조성물을 제공하는 것을 목적으로 한다.It is another object of the present invention to provide a photocurable antimicrobial coating composition which can be applied to various materials such as a liquid crystal film through mixing of a photocurable urethane acrylate and an antimicrobial peptide fusion adhesive protein.
본 발명의 특정한 장점들 및 신규한 특징들은 첨부된 도면들과 관련되어 이하의 상세한 설명과 바람직한 실시예로부터 더욱 명확해질 것이다.Certain advantages and novel features of the present invention will become more apparent from the following detailed description and preferred embodiments with reference to the accompanying drawings.
본 발명은 습한 환경이나 건조한 환경에서 자가 접착이 가능한 접착 단백질에 항균 펩티드가 유전공학적으로 부가된 항균 접착 단백질 및 이를 포함하는 항균 코팅 조성물을 제공한다.The present invention provides an antibacterial adhesive protein to which an antibacterial peptide is genetically added to an adhesive protein capable of self-adhesion in a humid environment or a dry environment, and an antibacterial coating composition comprising the same.
또한, 본 발명은 접착 단백질의 C-말단 또는 N-말단에 적어도 한 개 이상의 항균 펩티드를 부가하여 항균 기능이 우수한 항균 접착 단백질을 제공한다.Further, the present invention provides an antibacterial adhesive protein having an excellent antibacterial function by adding at least one antimicrobial peptide to the C-terminal or N-terminal of the adhesive protein.
본 발명의 한 구현예에 따르면, 항균 펩티드가 부가된 항균 홍합 접착 단백질의 티로신 부분을 DOPA로 치환함으로써, 다양한 표면에 간단하게 코팅이 가능한 항균 코팅 조성물을 제공할 수 있다.According to one embodiment of the present invention, an antimicrobial coating composition capable of being simply coated on various surfaces can be provided by replacing the tyrosine portion of the antibacterial mussel adhesive protein to which the antibacterial peptide is added with DOPA.
또한, 본 발명은 수용성 우레탄 아크릴레이트와 항균 펩티드가 부가된 접착 단백질을 포함하는 UV 광경화형 코팅 조성물을 제공한다.
The present invention also provides a UV light curable coating composition comprising a water soluble urethane acrylate and an adhesive protein to which an antimicrobial peptide has been added.
이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
본 발명은 항균 접착 단백질을 단독으로, 또는 상기 항균 접착 단백질과 광경화형 우레탄 아크릴레이트 계열의 접착 수지의 혼합물을 포함하는 항균 코팅 조성물을 제공한다. 본 발명에서 제공하는 항균 코팅 조성물은 자연적으로 존재하거나 인공적으로 고안된 항균 펩티드로 기능화된 항균 접착 단백질로 구성되며, 항균 접착 단백질의 기본적인 구조는 X-P-Y로 구성된다. 상기 X와 Y는 항균 펩티드이고, P는 접착 단백질이다. 임의의 적합한 항균 접착 단백질이 본 발명의 코팅 조성물에 사용될 수 있다.The present invention provides an antimicrobial coating composition comprising an antimicrobial adhesive protein alone or a mixture of the antimicrobial adhesive protein and a photocurable urethane acrylate-based adhesive resin. The antimicrobial coating composition provided in the present invention is composed of an antibacterial adhesive protein functionalized with an antimicrobial peptide present naturally or artificially, and the basic structure of the antibacterial adhesive protein is composed of X-P-Y. X and Y are antimicrobial peptides, and P is an adhesive protein. Any suitable antimicrobial adhesive protein may be used in the coating compositions of the present invention.
본 발명의 항균 접착 단백질에 적용되는 접착 단백질은 자가 접착이 가능한 모든 단백질을 제한없이 포함한다. 자가 접착 단백질은 본질적으로 접착성을 보유하거나 혹은 화학적 개질을 통해 접착성이 부가된 임의의 단백질을 포함한다. 시판되는 자가 접착 단백질의 예로는 미국 사우스캐롤리나주 노스 오구스타 소재 콜로디스 바이오사이언스사에 의해 시판되고 있는 홍합 유래 재조합 접착 단백질인 MAPTrix™ 이 있지만 이에 한정되는 것은 아니다. 화학적 개질을 통해 접착성이 부가된 접착 단백질의 예로는 아크릴레이트로 개질된 단백질을 들 수 있다. 예를 들면, 아크릴레이트화된 콜라겐 혹은 홍합 접착 단백질을 들 수 있으나, 이에 한정되는 것은 아니다. 본 발명의 한 구현예에서는 아크릴레이트화된 홍합 접착 단백질로 구성된 항균 코팅 조성물을 제공한다.The adhesive protein applied to the antimicrobial adhesive protein of the present invention includes all proteins capable of self-adhesion without limitation. Self-adhesive proteins include any protein that inherently has adhesive properties or is adhered via chemical modification. Examples of commercially available self-adhesive proteins include, but are not limited to MAPTrix ™, a mussel-derived recombinant adhesive protein marketed by Colodis Biosciences, Inc., North Ogsta, South Carolina. An example of an adhesive protein to which adhesiveness has been imparted through chemical modification is a protein modified with an acrylate. Examples include, but are not limited to, acrylated collagen or mussel adhesive proteins. One embodiment of the present invention provides an antimicrobial coating composition comprising an acrylated mussel adhesive protein.
본 발명의 한 구현예에서 제공하는 MAPTrix™은 유전자 재조합적으로 기능화된 홍합 접착 단백질이다. 본 발명에 있어서, 상기 홍합 접착 단백질은 그 자체로 사용하거나, 서열번호 10, 11, 12 또는 13으로 기재되는 족사 단백질(foot protein, FP) 5(FP-5) 또는 서열번호 5, 6, 7 또는 8로 기재되는 FP-3, 서열번호 14로 기재되는 FP-6의 C-말단이나 N-말단 혹은 양쪽 모두에 해당하는 제1 펩티드와 홍합 접착 단백질 FP-1(서열번호 1), FP-2(서열번호 4), FP-4(서열번호 9) 및 각 단백질의 절편으로 이루어진 군으로부터 선택되는 적어도 하나의 제2 펩티드가 융합된 융합 단백질로서 사용될 수 있다. 바람직하게는, 상기 제1 펩티드는 서열번호 10, 11, 12 또는 13의 아미노산 서열을 포함하는 FP-5이고, 상기 제2 펩티드는 서열번호 1, 2 또는 3의 아미노산 서열을 포함하는 FP-1이다. 본 발명의 한 구현예에 따르면, 상기 홍합 접착 단백질은 서열번호 1 내지 서열번호 19로 이루어진 군으로부터 선택되는 아미노산 서열을 갖는 것이 바람직하지만, 이에 한정되는 것은 아니다. 본 발명에 있어서, 항균 펩티드는 상기 접착 단백질, 바람직하게는 홍합 접착 단백질에 항균 기능을 부가하기 위해 필요하다.MAPTrix (TM) provided in one embodiment of the present invention is a recombinantly functionalized mussel adhesive protein. In the present invention, the mussel adhesive protein may be used as such or may be a foot protein (FP-5) (SEQ ID NO: 10, 11, 12 or 13) (SEQ ID NO: 1), FP-3 (SEQ ID NO: 1), FP-3 described in SEQ ID NO: 2 (SEQ ID NO: 4), FP-4 (SEQ ID NO: 9), and fragments of the respective proteins can be used as the fusion protein fused with at least one second peptide. Preferably, the first peptide is FP-5 comprising the amino acid sequence of SEQ ID NO: 10, 11, 12 or 13 and the second peptide is FP-1 comprising the amino acid sequence of SEQ ID NO: 1, 2 or 3 to be. According to one embodiment of the present invention, the mussel adhesive protein preferably has an amino acid sequence selected from the group consisting of SEQ ID NO: 1 to SEQ ID NO: 19, but is not limited thereto. In the present invention, the antimicrobial peptide is necessary to add an antibacterial function to the adhesive protein, preferably the mussel adhesive protein.
상기 항균 펩티드는 유전자 재조합 기술로 홍합 접착 단백질의 C-말단이나, N-말단, 혹은 양쪽 모두 혹은 하이브리드 홍합 접착 단백질의 사이에 부가될 수 있다. 예를 들면, 2 개의 FP-1 사이에 1 개의 FP-5이 결합된 구조를 갖는 융합 단백질 FP-151의 경우 FP-1과 FP-5 사이에 항균 펩티드를 부가할 수 있다. 또한, 양 말단이나 융합 단백질 사이에 서로 다른 항균 펩티드를 부가할 수 있다. 예를 들면, 본 발명의 항균 펩티드를 포함하는 접착 단백질은 아프리카 개구리 제노퍼스 래비스(Xenopus laevis)의 피부로부터 분리된 α-나선형 23개 아미노산 펩티드인 마가이닌(Magainin)이나 더마셉틴(Dermaseptin)과 같은 항균 펩티드를 제한없이 포함할 수 있으며, 또한 인간 디펜신(human defensin), 카세리시딘(cathelicidin) LL-37, 히스타틴(Histatin)과 같은 항균 펩티드가 포함될 수 있으나, 이에 한정되는 것은 아니다.The antimicrobial peptide may be added at the C-terminal, N-terminal, or both, or between hybrid mussel adhesive proteins of a mussel adhesive protein by gene recombination technology. For example, an antimicrobial peptide may be added between FP-1 and FP-5 in the case of the fusion protein FP-151 having a structure in which one FP-5 is bound between two FP-1. In addition, different antimicrobial peptides can be added between both ends or the fusion protein. For example, the adhesive proteins comprising the antimicrobial peptides of the present invention can be used in combination with the alpha-helical 23 amino acid peptides Magainin or Dermaseptin isolated from the skin of the African frog Genopus laevis But are not limited to, antimicrobial peptides such as human defensin, cathelicidin LL-37, and histatin. The antimicrobial peptides of the present invention may be used alone or in combination.
본 발명에서 접착 단백질에 융합되는 항균 펩티드는 자연에서 유래하거나 인공적으로 합성되는 임의의 펩티드를 제한없이 사용할 수 있다. 본 발명의 한 구현예에 따르면, 상기 항균 펩티드는 미생물의 세포막을 파괴하거나 세포막을 투과하여 대사 기능을 저해하는 기작을 통해 항균 효과를 발휘한다. 본 발명의 다른 구현예에 따르면, 미생물의 세포막을 파괴하는 기작을 통해 항균 효과를 발휘하는 임의의 항균 펩티드는 모두 본 발명에 사용될 수 있다. 바람직하게는, 접착 단백질에 융합될 항균 펩티드는 그램 양성균은 물론 그램 음성균에 효과가 있는 항균 펩티드 중에서 임의로 선택될 수 있다. 보다 바람직하게는 KLWKKWAKKWLKLWKA(서열번호 20), FALALKALKKL(서열번호 21), ILRWPWWPWRRK(서열번호 22), AKRHHGYKRKFH(서열번호 23), KWKLFKKIGAVLKVL(서열번호 24), LVKLVAGIKKFLKWK(서열번호 25), IWSILAPLGTTLVKLVAGIGQQKRK(서열번호 26), GIGAVLKVLTTGLPALISWI(서열번호 27), SWLSKTAKKGAVLKVL(서열번호 28), KKLFKKILKYL(서열번호 29), GLKKLISWIKRAAQQG(서열번호 30) 및 GWLKKIGKKIERVGQHTRDATIQGLGIAQQAANVAATAR(서열번호 31)에서 선택될 수 있다.The antimicrobial peptide fused to the adhesive protein in the present invention may be any natural peptide or artificially synthesized peptide without limitation. According to one embodiment of the present invention, the antimicrobial peptide exhibits an antimicrobial effect through a mechanism that disrupts the cell membrane of the microorganism or permeates the cell membrane to inhibit the metabolic function. According to another embodiment of the present invention, any antimicrobial peptide exhibiting an antimicrobial effect through a mechanism of destroying the cell membrane of a microorganism can be used in the present invention. Preferably, the antimicrobial peptide to be fused to the adhesive protein may be selected from among antimicrobial peptides effective against gram-positive bacteria as well as gram-negative bacteria. KLWKKWAKKWLKLWKA (SEQ ID NO: 20), FALALKALKKL (SEQ ID NO: 21), ILRWPWWPWRRK (SEQ ID NO: 22), AKRHHGYKRKFH (SEQ ID NO: 23), KWKLFKKIGAVLKVL (SEQ ID NO: 24), LVKLVAGIKKLKWK (SEQ ID NO: 25), IWSILAPLGTTLVKLVAGIGQQKRK 26), GIGAVLKVLTTGLPALISWI (SEQ ID NO: 27), SWLSKTAKKGAVLKVL (SEQ ID NO: 28), KKLFKKILKYL (SEQ ID NO: 29), GLKKLISWIKRAAQQG (SEQ ID NO: 30) and GWLKKIGKKERVGQHTRDATIQGLGIAQQAANVAATAR (SEQ ID NO: 31).
본 발명의 한 구현예에 따르면, 광범위한 항균 효과를 가진 항균 접착 단백질을 제공하기 위하여 서로 다른 항균 펩티드가 접착 단백질의 C-말단과 N-말단에 부가된 항균 접착 단백질에 기반한 코팅 조성물을 제공한다. 본 발명에서 광범위한 항균 코팅 조성물을 제공하며, 바람직하게는 본 항균 코팅 조성물은 C-말단에 그램 음성균에 효과가 있는 펩티드 FALALKALKKL(서열번호 21)가 부가되고 N-말단에 그램 양성균에 효과가 있는 펩티드 AKRHHGYKRKFH(서열번호 23)가 부가된 항균 접착 단백질로 구성된다.According to one embodiment of the present invention, there is provided a coating composition based on an antibacterial adhesive protein wherein different antibacterial peptides are added to the C-terminus and N-terminus of an adhesive protein in order to provide an antibacterial adhesive protein having a broad antibacterial effect. The present invention provides a broad range of antimicrobial coating compositions, preferably wherein the antimicrobial coating composition comprises a peptide having a peptide FALALKALKKL (SEQ ID NO: 21) at the C-terminus that is effective against Gram-negative bacteria and having an effect on gram- AKRHHGYKRKFH (SEQ ID NO: 23).
본 발명에서 항균 펩티드 융합 홍합 접착 단백질은 구성 아미노산 중에서 티로신 잔기는 화학적 수정을 통하여 DOPA, 그리고 더 나아가 DOPA 퀴논으로 바뀌며, 이렇게 수정된 DOPA 및 DOPA 퀴논은 표면에 대한 접착에 있어서 매우 중요한 역할을 할 수 있다. 본 발명의 한 구현예에 따르면, 이러한 화학적 수정을 매개할 수 있는 버섯 유래의 티로시나아제(tyrosinase) 효소를 이용하여 재조합 홍합 접착 단백질의 화학적 수정을 수행할 수 있다. 화학적 수정을 거친 항균 홍합 접착 단백질은 금속, 플라스틱, 유리등 다양한 소재에 부착될 수 있다.In the present invention, the antimicrobial peptide fusion mussel adhesive protein is converted to DOPA and further to DOPA quinone through chemical modification of the tyrosine residues in the constituent amino acids. The modified DOPA and DOPA quinone can play a very important role in adhesion to the surface have. According to one embodiment of the present invention, a chemical modification of the recombinant mussel adhesive protein can be carried out using a mushroom-derived tyrosinase enzyme capable of mediating such chemical modification. The chemically modified antimicrobial mussel adhesive protein can be attached to a variety of materials such as metals, plastics, and glass.
항균 접착 단백질에 기반한 코팅 조성물 농도는 부가된 항균 펩티드에 따라 조정될 수 있다. 바람직하게는, 항균 코팅 조성물 내의 항균 접착 단백질의 농도는 0.01∼1% (wt/wt)이며, 보다 바람직하게는 0.01∼0.3% (wt/wt)이다.The concentration of the coating composition based on the antimicrobial adhesive protein can be adjusted according to the added antimicrobial peptide. Preferably, the concentration of antimicrobial adhesive protein in the antimicrobial coating composition is from 0.01 to 1% (wt / wt), more preferably from 0.01 to 0.3% (wt / wt).
본 발명의 항균 접착 단백질이 혼합된 수용성 아크릴레이트 계열의 항균 코팅 조성물은 UV 광경화형 항균 코팅제이다. 이때 항균 접착 단백질과 아크릴레이트를 먼저 혼합할 수 있다. 광개시제로는 벤조일 퍼록사이드, Irgacure 184 등이 사용될 수 있으나, 이에 한정되는 것은 아니다. 아크릴레이트와 항균 접착 단백질의 중량비는 1:0.01, 바람직하게는 1:0.001의 비율로 혼합된다.The water-soluble acrylate-based antimicrobial coating composition mixed with the antimicrobial adhesive protein of the present invention is a UV light-curable antimicrobial coating agent. At this time, the antimicrobial adhesive protein and the acrylate can be mixed first. As the photoinitiator, benzoyl peroxide and Irgacure 184 may be used, but the present invention is not limited thereto. The weight ratio of the acrylate to the antibacterial adhesive protein is mixed at a ratio of 1: 0.01, preferably 1: 0.001.
본 발명의 한 구현예에 따르면, 본 발명에서 사용되는 아크릴레이트는 임의의 수용성 아크릴레이트가 제한없이 사용될 수 있다. 본 발명에서 제공하는 항균 코팅 조성물은 우레탄 아크릴레이트, 폴리에스테르 아크릴레이트, 에폭시 아크릴레이트 중에서 하나 이상 선택된 수용성 아크릴레이트와 항균 접착 단백질로 구성된다.According to one embodiment of the present invention, the acrylate used in the present invention may be any water soluble acrylate without any limitation. The antimicrobial coating composition provided in the present invention is composed of a water-soluble acrylate and an antibacterial adhesive protein selected from at least one of urethane acrylate, polyester acrylate and epoxy acrylate.
또한, 본 발명은 항균 접착 단백질을 포함하는 UV 광경화형 항균 코팅 조성물을 포함하는 항균 기능성 필름을 제공한다.The present invention also provides an antibacterial functional film comprising a UV photocurable antimicrobial coating composition comprising an antibacterial adhesive protein.
상기 항균 조성물로 코팅된 항균 필름을 제조하기 위해 사용되는 필름은 통상적으로 식품 포장, 휴대폰, 예컨대 스마트폰의 액정 보호용 등으로 흔히 사용되는 폴리에틸렌 또는 폴리프로필렌 필름일 수 있으나, 이에 한정되는 것은 아니다. 도포되는 UV 광경화형 항균 조성물의 양은 항균 접착 단백질의 양, 코팅 대상의 종류 등을 고려하여 적절히 선택될 수 있다.The film used to produce the antimicrobial film coated with the antimicrobial composition may be a polyethylene or polypropylene film commonly used for food packaging, mobile phones, liquid crystal protection of smart phones, and the like, but is not limited thereto. The amount of the UV photocurable antimicrobial composition to be applied can be appropriately selected in consideration of the amount of the antibacterial adhesive protein, the kind of the coating object, and the like.
본 발명의 한 구현예에 따르면, 폴리스티렌 필름에 항균 접착 단백질이 포함된 우레탄 아크릴레이트를 도포한 후 광경화하여 항균 코팅 필름을 제조할 수 있다. 본 발명의 다른 구현예에 따르면, 상기 항균 코팅 필름의 항균력은 그람 음성균, 예를 들면 대장균을 대상으로 하여 코팅되지 않은 표면과 코팅된 표면에서의 균 감소율을 확인할 수 있다.According to one embodiment of the present invention, an antimicrobial coating film can be prepared by applying a urethane acrylate containing an antibacterial adhesive protein to a polystyrene film, followed by photocuring. According to another embodiment of the present invention, the antimicrobial activity of the antimicrobial coating film can be confirmed by examining the antimicrobial activity of Gram-negative bacteria, for example, E. coli, on the uncoated surface and the coated surface.
항균 접착 단백질을 단독으로, 또는 상기 항균 접착 단백질과 아크릴레이트가 혼합된 본 발명의 광경화형 항균 코팅 조성물은 휴대폰의 액정 보호 필름, 식품 포장재, 의료기구 등의 표면에 코팅되어 유해 미생물에 대한 안정성을 확보할 수 있는 효과가 있다. 특히, 본 발명의 항균 접착 단백질은 홍합 접착 단백질의 강력한 접착력을 바탕으로 항균성이 지속적으로 유지됨으로써, 항균 물질에 용출에 의한 항균력 감소를 방지할 수 있다.The photocurable antimicrobial coating composition of the present invention, in which the antimicrobial adhesive protein alone or in combination with the above-mentioned antimicrobial adhesive protein and acrylate is coated on the surface of a liquid crystal protective film, a food packaging material, a medical instrument or the like of a mobile phone, There is an effect that can be secured. In particular, the antimicrobial adhesive protein of the present invention maintains antimicrobial activity on the basis of the strong adhesive force of the mussel adhesive protein, thereby preventing the antimicrobial activity from being reduced due to elution into the antimicrobial substance.
본 발명의 상기 기술된 특징들과 또 다른 특징 및 장점들은 예시적인 목적으로 제공되는 하기 구현예들과 도면들을 함께 고려할 때 분명할 것이다.
도 1은 항균 코팅 조성물의 핵심인 항균 접착 단백질의 기본 구조를 나타내는 도면이다.
도 2은 항균 펩티드 A가 융합된 항균 접착 단백질의 대장균에 대한 항균력을 보여주는 사진이다.
도 3은 항균 펩티드 B가 융합된 항균 접착 단백질의 대장균에 대한 항균력을 보여주는 사진이다.
도 4은 항균 펩티드 C가 융합된 항균 접착 단백질의 대장균에 대한 항균력을 보여주는 사진이다.
도 5은 항균 펩티드 D가 융합된 항균 접착 단백질의 대장균에 대한 항균력을 보여주는 사진이다.
도 6은 화학 수정된 항균 펩티드 A가 융합된 홍합 접착 단백질이 폴리스티렌 표면에 코팅된 후, 표면에서의 대장균에 대한 항균력을 보여주는 사진이다.
도 7은 화학 수정된 항균 펩티드 A가 융합된 홍합 접착 단백질이 폴리스티렌 표면에 코팅된 후, 표면에서의 대장균에 대한 항균 지속성을 보여주는 사진이다.
도 8은 수용성 아크릴레이트와 항균 접착 단백질로 구성된 항균 코팅 조성물로 과산화물을 이용하여 제조된 항균 코팅 표면에서의 항균 효과를 보여주는 사진이다.The above-described and other features and advantages of the present invention will be apparent upon consideration of the following embodiments and drawings provided for illustrative purposes.
1 is a diagram showing the basic structure of an antibacterial adhesive protein which is the core of an antibacterial coating composition.
2 is a photograph showing the antibacterial activity of an antibacterial adhesive protein fused with the antimicrobial peptide A against E. coli.
Fig. 3 is a photograph showing the antibacterial activity of the antibacterial adhesive protein fused with the antimicrobial peptide B against E. coli. Fig.
4 is a photograph showing the antibacterial activity of an antibacterial adhesive protein fused with the antimicrobial peptide C against E. coli.
5 is a photograph showing the antibacterial activity of an antibacterial adhesive protein fused with the antimicrobial peptide D against E. coli.
FIG. 6 is a photograph showing the antibacterial activity against E. coli on the surface after the mussel adhesive protein fused with the chemically modified antibacterial peptide A is coated on the polystyrene surface.
7 is a photograph showing the antimicrobial persistence of E. coli on the surface after the mussel adhesive protein fused with the chemically modified antimicrobial peptide A is coated on the polystyrene surface.
8 is a photograph showing antibacterial effect on an antimicrobial coating surface prepared by using peroxide as an antimicrobial coating composition composed of a water-soluble acrylate and an antibacterial adhesive protein.
이하, 본 발명을 실시예에 의해 상세히 설명한다.Hereinafter, the present invention will be described in detail by way of examples.
단, 하기 실시예는 본 발명을 예시하기 위한 것일 뿐, 본 발명의 내용이 하기 실시예에 의해 한정되는 것은 아니다. 또한, 본 발명에 개시된 바와 같이, 기능적으로 동일한 제품, 조성물 및 방법은 모두 본 발명의 범위에 포함되는 것이 자명하다.
However, the following examples are for illustrative purposes only and are not intended to limit the scope of the present invention. Also, as disclosed in the present invention, all functionally equivalent products, compositions and methods are included within the scope of the present invention.
실시예Example 1. 항균 펩티드가 융합된 홍합 접착 단백질의 발현 벡터 제조 1. Preparation of Expression Vector of Mussel Adhesion Protein Fused with Antibacterial Peptides
항균 펩티드가 융합된 홍합 접착 단백질의 제조를 위하여, 홍합 접착 단백질의 C-말단 혹은 N-말단 부위에 통상적인 항균 펩티드 서열이 부가된 유전서열을 설계하여 노바셀테크놀로지(Novacell Technology, 한국)에 발현 벡터 제작을 의뢰하였다. 제작 완료된 벡터는 E. coli BL21(DE3)로 형질전환되었으며, 부가된 서열은 표 1과 같다.In order to prepare a mussel adhesive protein fused with an antimicrobial peptide, a genetic sequence to which a conventional antimicrobial peptide sequence was added at the C-terminal or N-terminal site of the mussel adhesive protein was designed and expressed in Novacell Technology (Korea) I commissioned the production of a vector. The constructed vector was transformed into E. coli BL21 (DE3), and the added sequence is shown in Table 1.
실시예Example 2. 항균 펩티드가 융합된 홍합 접착 단백질의 제조 2. Preparation of Mussel Adhesion Protein Fused with Antibacterial Peptides
2.1. E. 2.1. E. colicoli BL21BL21 (( DE3DE3 ) 배양) Culture
E. coli BL21(DE3)는 LB(5 g/L yeast extract, 10 g/L Tryptone 및 10 g/L NaCl) 배지에 배양하고, 배양액의 흡광도가 600 ㎚에서 0.6 정도가 되었을 때 IPTG를 최종농도 1 mM로 첨가하여 재조합 항균 펩티드 융합 홍합 접착 단백질의 발현을 유도하였다. E. coli BL21(DE3) 배양액은 13,000 rpm, 4에서 10분간 원심분리하여 세포 펠렛을 수득하였고, 이를 -80℃에 보관하였다.E. coli BL21 (DE3) was cultured in LB (5 g / L yeast extract, 10 g / L Tryptone and 10 g / L NaCl) medium. When the absorbance of the culture reached 0.6 at 600 ㎚, 1 mM to induce the expression of recombinant antimicrobial peptide fusion mussel adhesive protein. The E. coli BL21 (DE3) culture broth was centrifuged at 13,000 rpm for 4 to 10 minutes to obtain cell pellets, which were stored at -80 ° C.
2.2. 항균 펩티드가 융합된 홍합 접착 단백질의 발현 확인2.2. Expression of Mussel Adhesion Protein Fused with Antibacterial Peptides
세포 펠렛은 SDS-PAGE용 완충액(0.5 M Tris-HCl, pH 6.8, 10% glycerol, 5% SDS, 5% β-mercaptoethanol, 0.25% bromophenol blue) 100 ㎍에 희석하고, 100℃에서 5분간 끓여 변성시켰다. SDS-PAGE의 경우 시료를 15% SDS-폴리 아크릴아마이드 젤에 전기영동한 후 쿠마시 블루(Coomasie blue) 염색을 이용해 단백질 밴드를 검출하여 확인하였다.
The cell pellet was diluted with 100 μg of SDS-PAGE buffer (0.5 M Tris-HCl, pH 6.8, 10% glycerol, 5% SDS, 5% β-mercaptoethanol, 0.25% bromophenol blue) and boiled at 100 ° C. for 5 minutes to denature . For SDS-PAGE, the sample was electrophoresed on a 15% SDS-polyacrylamide gel and protein bands were detected using Coomassie blue staining.
2.3. 항균 펩티드가 융합된 홍합 접착 단백질의 정제2.3. Purification of mussel adhesive proteins fused with antimicrobial peptides
상기 실시예 2.1.에서 수득된 세포 펠렛은 용해 버퍼(2.4 g/L sodium phosphate monobasic, 5.6 g/L sodium phosphate dibasic, 10 mM EDTA 및 1% Triton X-100)를 사용하여 교반하였고, 고압 파쇄기를 사용하여 세포를 파쇄하였다. 파쇄물은 9,000 rpm으로 20분간 원심분리하여 홍합 접착 단백질을 포함하는 불용성 단백질 응집체를 수득하였다. 불용성 단백질 응집체로부터 25% 아세트산을 사용하여 항균 펩티드가 융합된 홍합 접착 단백질을 추출하였고, 9,000 rpm으로 20분간 원심분리하여 홍합 접착 단백질을 포함하는 상층액을 회수하였다. 회수된 상층액은 10 N NaOH를 사용하여 pH 12.8까지 상승시켰, 동일한 조건으로 원심분리하여 상층액을 회수하였다. 상층액은 아세트산을 사용하여 pH 6∼7 까지 중화적정한 후, 동일한 조건으로 원심분리하여 항균 펩티드 융합 홍합 접착 단백질의 침전물을 수득하였다. 수득된 침전물을 적정량의 정제수로 용해한 후 동결건조하여, 순도 90% 이상의 항균 펩티드 융합 홍합 접착 단백질 동결 건조물을 수득하였다.
The cell pellet obtained in Example 2.1 was stirred using a dissolution buffer (2.4 g / L sodium phosphate monobasic, 5.6 g / L sodium phosphate dibasic, 10 mM EDTA and 1% Triton X-100) To disrupt the cells. The lysate was centrifuged at 9,000 rpm for 20 minutes to obtain an insoluble protein aggregate containing mussel adhesive protein. The mussel adhesive protein fused with the antimicrobial peptide was extracted from the insoluble protein aggregate using 25% acetic acid and centrifuged at 9,000 rpm for 20 minutes to recover the supernatant containing the mussel adhesive protein. The recovered supernatant was raised to pH 12.8 with 10 N NaOH, and the supernatant was recovered by centrifugation under the same conditions. The supernatant was neutralized to pH 6-7 with acetic acid and then centrifuged under the same conditions to obtain a precipitate of the antibacterial peptide fusion mussel adhesive protein. The obtained precipitate was dissolved in an appropriate amount of purified water and then lyophilized to obtain an antifungal peptide fusion mussel adhesive protein freeze-dried product having a purity of 90% or more.
실시예Example 3. 항균 펩티드가 융합된 홍합 접착 단백질의 항균력 시험 3. Antibacterial activity of mussel adhesive protein with antimicrobial peptide fused
먼저 항균 펩티드가 융합된 홍합 접착 단백질 A, B, C, D를 농도별로 준비하였다. 항균력 시험을 위한 농도는 PBS(phosphate buffered saline) 버퍼 용액을 사용하여 10∼0.01 ㎎/㎖로 준비하였다. 항균력 시험 균주로는 그람 음성균인 대장균을 사용하였으며, 대장균을 LB 배지에서 37℃, 150 rpm에서 흡광도 1.0까지 진탕배양하였다. 흡광도 1.0에서 대장균 배양액을 104 CFU/㎖이 되도록 PBS로 희석한 후, 미리 준비된 항균 펩티드 융합 단백질과 멸균된 튜브에 9:1의 비율로 혼합하였고, 항온 항습기에서 37℃ 온도에서 1시간 동안 배양하였다. 1시간 후, 각 튜브로부터 대장균액을 100 ㎕씩 분취하여 한천 배지에 도말한 후, 24시간 동안 동일한 조건에서 배양하였다.First, mussel adhesive proteins A, B, C and D, in which antimicrobial peptides were fused, were prepared by concentration. The concentration for the antimicrobial activity test was adjusted to 10-0.01 ㎎ / ㎖ by using PBS (phosphate buffered saline) buffer solution. Escherichia coli, which is a Gram-negative bacterium, was used as a test strain for the antimicrobial activity. Escherichia coli was cultured in LB medium at 37 DEG C and 150 rpm for an absorbance of 1.0. The E. coli culture broth was diluted with PBS to 10 4 CFU / ml at an absorbance of 1.0, mixed with a pre-prepared antimicrobial peptide fusion protein and a sterilized tube at a ratio of 9: 1, incubated at 37 ° C for 1 hour Respectively. One hour later, 100 쨉 l of E. coli was collected from each tube, plated on an agar medium, and cultured for 24 hours under the same conditions.
그 결과, 도 1 내지 도 4에 나타낸 바와 같이, 본 발명의 항균 펩티드 융합 홍합 단백질은 대조군과 비교하여 99.99%의 항균 효과를 갖는 것으로 나타났다.As a result, as shown in Fig. 1 to Fig. 4, the antimicrobial peptide fusion mussel protein of the present invention showed an antibacterial effect of 99.99% as compared with the control group.
도 3에 나타난 바와 같이 항균 접착제의 농도 효과를 확인한 결과, 항생제 농도보다 더 낮은 농도인 1 ㎎/㎖에서도 대장균 사멸 효과가 우수함을 확인할 수 있었다.
As shown in FIG. 3, the concentration effect of the antimicrobial adhesive was confirmed. As a result, it was confirmed that the effect of the antimicrobial adhesive was excellent even at a concentration of 1 mg / ml which is lower than the antibiotic concentration.
실시예Example 4. 항균 단백질의 자가 접착력을 위한 티로시나아제 효소 처리 4. Tyrosinase enzyme treatment for self-adhesion of antimicrobial protein
동결건조된 항균 펩티드 융합 홍합 단백질 각각은 25 mM 아스코르빈산과 20 mM 나트륨 보레이트를 포함하는 0.1 M 나트륨 아세테이트 버퍼에 1 ㎎/㎖의 농도로 녹인 후, 산소 가스를 주입하여 30분 동안 항균 접착 단백질 용액내 산소를 포화시켰다. 이 후, 항균 접착 단백질 1 ㎎ 당 40∼1 ㎍, 바람직하게는 5∼1 ㎍의 농도로 티로시나아제를 첨가한 후, 산소를 주입하면서 1시간 동안 교반하였다. 1시간 후, 5% 아세트산을 첨가하여 화학적 수정 반응을 종료하였다. 반응 종료된 홍합 단백질 용액은 동결건조를 진행하여 분말로 수득하였다. 상기 과정을 통하여 항균 접착 단백질의 티로신 잔기를 DOPA로 수정하였다.Each of the lyophilized antimicrobial peptide fusion mussel proteins was dissolved at a concentration of 1 mg / ml in 0.1 M sodium acetate buffer containing 25 mM ascorbic acid and 20 mM sodium borate, The oxygen in the solution was saturated. After that, tyrosinase was added at a concentration of 40 to 1 占 퐂, preferably 5 to 1 占 퐂 / 1 mg of the antibacterial adhesive protein, followed by stirring for 1 hour while injecting oxygen. After 1 hour, 5% acetic acid was added to terminate the chemical modification reaction. The reaction-completed mussel protein solution was lyophilized and obtained as a powder. Through the above process, the tyrosine residue of the antibacterial adhesive protein was modified to DOPA.
효소 처리된 항균 접착 단백질의 자가 접착력 확인과, 표면 코팅 시험과 효소 처리 과정이 항균력에 미치는 영향을 파악하기 위하여 항균력 시험을 진행하였다. 먼저, 항균 펩티드 융합 홍합 단백질 A를 농도별로 준비하였다. 항균력 시험을 위한 농도는 PBS 버퍼 용액을 사용하여 10∼0.01 ㎎/㎖로 준비하였다. 해당 용액은 세포 배양용 폴리스티렌 재질의 플레이트에 전체적으로 퍼지게 도포하였고, 잔여 용액은 회수하였다. 24시간 동안 Laminar flow 하에서 건조시킨 후, 멸균된 PBS로 3회 표면을 세척였고, 다시 24시간 동안 건조시켰다. 표면이 완전히 건조되면, 전 배양된 대장균 시험액을 104 CFU/㎖이 되도록 PBS로 희석한 후, 표면 코팅된 플레이트에 1 ㎖씩 분주하였다. 항온 항습기에서 37℃ 온도에서 1시간 동안 배양한 후, 각 플레이트 대장균액을 100 ㎕씩 분취하여 한천 배지에 도말하였고, 24시간동안 동일한 조건에서 배양하였다.The antimicrobial activity of the enzyme - treated antimicrobial adhesive protein was examined in order to examine the effect of the self - adhesive force, surface coating test and enzyme treatment on the antimicrobial activity. First, an antimicrobial peptide fusion mussel protein A was prepared for each concentration. The concentration for the antimicrobial activity test was adjusted to 10-0.01 mg / ml using PBS buffer solution. The solution was spread on a plate made of polystyrene for cell culture as a whole, and the remaining solution was recovered. After drying for 24 hours under Laminar flow, the surface was washed three times with sterile PBS and dried again for 24 hours. When the surface was completely dried, the pre-cultured Escherichia coli test solution was diluted with PBS to 10 4 CFU / ml, and then 1 ml each was dispensed onto the surface-coated plate. After incubation for 1 hour at 37 ° C in a thermo-hygrostat, 100 μl of each plate coliform solution was aliquotted onto an agar medium and incubated for 24 hours under the same conditions.
그 결과, 항균 펩티드 융합 홍합 단백질은 0.1% 농도의 단백질 용액을 표면 코팅하였을 때, 대조군과 비교하여 99.99%의 항균 효과를 갖는 것으로 나타났다(도 5). 또한, 항균 지속성을 테스트하기 위하여, 상기에서 대장균 시험액이 분주되었던 플레이트를 1주일 후 동일한 과정으로 세척하여 동일한 테스트를 반복한 결과 항균력이 유지됨을 확인하였다(도 6).
As a result, the antimicrobial peptide fusion mussel protein showed an antimicrobial effect of 99.99% as compared with the control group when the 0.1% protein solution was coated on the surface (FIG. 5). In order to test the antimicrobial persistence, the plate in which the E. coli test solution was dispensed was washed with the same procedure after one week, and the same test was repeated to confirm that the antibacterial activity was maintained (FIG. 6).
실시예Example 5. 항균 접착 단백질을 포함하는 5. Containing antibacterial adhesive proteins UVUV 광경화형 우레탄 Light-curing urethane 아크릴레이트Acrylate 조성물의 제조 Preparation of composition
우레탄 아크릴레이트 1 g을 0.5∼1 ㎖, 바람직하게는 0.5 ㎖의 에탄올에 녹인 후 항균 홍합 단백질 A 5 ㎎이 용해된 에탄올 수용액 0.5 ㎖과 혼합하였다. 항균 홍합 단백질-아크릴레이트 혼합물에 벤질 퍼옥사이드 30 ㎎이 용해된 아세톤/에탄올 용액 0.2 ㎖을 가한 후 90℃로 가열된 UV 룸 (파장 285nm)에서 2개의 UV 전구에 노광하고 10분간 경화반응을 시켜 항균 필름을 제조하였다. 제조된 항균 필름의 항균력 시험은 상기 실시예 3과 동일한 방법과 절차에 따라 대장균을 대상으로 시행하였다.1 g of urethane acrylate was dissolved in 0.5 to 1 ml, preferably 0.5 ml of ethanol, and then mixed with 0.5 ml of an aqueous ethanol solution in which 5 mg of antibacterial mussel protein A was dissolved. 0.2 ml of an acetone / ethanol solution in which 30 mg of benzyl peroxide was dissolved was added to the antibacterial mussel protein-acrylate mixture, and then exposed to two UV bulbs in a UV room (wavelength: 285 nm) heated to 90 ° C and subjected to a curing reaction for 10 minutes An antimicrobial film was prepared. The antibacterial activity of the prepared antimicrobial film was tested for E. coli according to the same method and procedure as in Example 3 above.
그 결과, 도 8에 나타난바와 같이 코팅되지 않은 대조군(A)과 비교하여, 항균 펩티드 융합 홍합 접착 단백질을 함유하는 광경화형 아크릴레이트가 코팅된 필름 표면(B, C)에서의 대장균 생육은 관찰되지 않았다.As a result, as compared with the uncoated control group (A) as shown in Fig. 8, E. coli growth on the photocurable acrylate-coated film surface (B, C) containing the antibacterial peptide fusion mussel adhesive protein was not observed I did.
<110> Kollodis Bioscience Co. Ltd. <120> Adhesive Protein Comprising Antimicrobial Peptide and Antimicrobial Coating Composition Comprising the Same <130> 2014-dpa-0823 <160> 31 <170> KopatentIn 2.0 <210> 1 <211> 10 <212> PRT <213> Artificial Sequence <220> <223> model peptide of the tandem repeat decapeptide derived from foot protein 1 (FP-1, Mytilus edulis) <400> 1 Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys 1 5 10 <210> 2 <211> 20 <212> PRT <213> Artificial Sequence <220> <223> 2 times repeated sequence derived from foot protein 1 (FP-1, Mytilus edulis) <400> 2 Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro 1 5 10 15 Pro Thr Tyr Lys 20 <210> 3 <211> 60 <212> PRT <213> Artificial Sequence <220> <223> 6 times repeated sequence derived from foot protein 1 (FP-1, Mytilus edulis) <400> 3 Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro 1 5 10 15 Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys 20 25 30 Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr 35 40 45 Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys 50 55 60 <210> 4 <211> 39 <212> PRT <213> Artificial Sequence <220> <223> partial sequence of foot protein type 2 (FP-2, Mytilus californianus) <400> 4 Glu Val His Ala Cys Lys Pro Asn Pro Cys Lys Asn Asn Gly Arg Cys 1 5 10 15 Tyr Pro Asp Gly Lys Thr Gly Tyr Lys Cys Lys Cys Val Gly Gly Tyr 20 25 30 Ser Gly Pro Thr Cys Ala Cys 35 <210> 5 <211> 52 <212> PRT <213> Artificial Sequence <220> <223> Foot protein type 3 (FP-3, Mytilus edulis) <400> 5 Ala Asp Tyr Tyr Gly Pro Lys Tyr Gly Pro Pro Arg Arg Tyr Gly Gly 1 5 10 15 Gly Asn Tyr Asn Arg Tyr Gly Gly Ser Arg Arg Tyr Gly Gly Tyr Lys 20 25 30 Gly Trp Asn Asn Gly Trp Lys Arg Gly Arg Trp Gly Arg Lys Tyr Tyr 35 40 45 Glu Phe Glu Phe 50 <210> 6 <211> 46 <212> PRT <213> Artificial Sequence <220> <223> Foot protein type 3 (FP-3, Mytilus galloprovincialis : mgfp-3A) <400> 6 Ala Asp Tyr Tyr Gly Pro Lys Tyr Gly Pro Pro Arg Arg Tyr Gly Gly 1 5 10 15 Gly Asn Tyr Asn Arg Tyr Gly Arg Arg Tyr Gly Gly Tyr Lys Gly Trp 20 25 30 Asn Asn Gly Trp Lys Arg Gly Arg Trp Gly Arg Lys Tyr Tyr 35 40 45 <210> 7 <211> 50 <212> PRT <213> Artificial Sequence <220> <223> Foot protein type 3 (FP-3, Mytilus edulis: mefp-3F) <400> 7 Ala Asp Tyr Tyr Gly Pro Asn Tyr Gly Pro Pro Arg Arg Tyr Gly Gly 1 5 10 15 Gly Asn Tyr Asn Arg Tyr Asn Gly Tyr Gly Gly Gly Arg Arg Tyr Gly 20 25 30 Gly Tyr Lys Gly Trp Asn Asn Gly Trp Asn Arg Gly Arg Arg Gly Lys 35 40 45 Tyr Trp 50 <210> 8 <211> 44 <212> PRT <213> Artificial Sequence <220> <223> Foot protein type 3 (FP-3, Mytilus californianus) <400> 8 Gly Ala Tyr Lys Gly Pro Asn Tyr Asn Tyr Pro Trp Arg Tyr Gly Gly 1 5 10 15 Lys Tyr Asn Gly Tyr Lys Gly Tyr Pro Arg Gly Tyr Gly Trp Asn Lys 20 25 30 Gly Trp Asn Lys Gly Arg Trp Gly Arg Lys Tyr Tyr 35 40 <210> 9 <211> 60 <212> PRT <213> Artificial Sequence <220> <223> partial sequence from foot protein type 4 (Mytilus californianus) <400> 9 Gly His Val His Arg His Arg Val Leu His Lys His Val His Asn His 1 5 10 15 Arg Val Leu His Lys His Leu His Lys His Gln Val Leu His Gly His 20 25 30 Val His Arg His Gln Val Leu His Lys His Val His Asn His Arg Val 35 40 45 Leu His Lys His Leu His Lys His Gln Val Leu His 50 55 60 <210> 10 <211> 75 <212> PRT <213> Artificial Sequence <220> <223> Foot protein type5 (FP-5, Mytilus edulis) <400> 10 Ser Ser Glu Glu Tyr Lys Gly Gly Tyr Tyr Pro Gly Asn Ala Tyr His 1 5 10 15 Tyr His Ser Gly Gly Ser Tyr His Gly Ser Gly Tyr His Gly Gly Tyr 20 25 30 Lys Gly Lys Tyr Tyr Gly Lys Ala Lys Lys Tyr Tyr Tyr Lys Tyr Lys 35 40 45 Asn Ser Gly Lys Tyr Lys Tyr Leu Lys Lys Ala Arg Lys Tyr His Arg 50 55 60 Lys Gly Tyr Lys Lys Tyr Tyr Gly Gly Ser Ser 65 70 75 <210> 11 <211> 76 <212> PRT <213> Artificial Sequence <220> <223> Foot protein 5 (FP-5, Mytilus edulis) <400> 11 Ser Ser Glu Glu Tyr Lys Gly Gly Tyr Tyr Pro Gly Asn Thr Tyr His 1 5 10 15 Tyr His Ser Gly Gly Ser Tyr His Gly Ser Gly Tyr His Gly Gly Tyr 20 25 30 Lys Gly Lys Tyr Tyr Gly Lys Ala Lys Lys Tyr Tyr Tyr Lys Tyr Lys 35 40 45 Asn Ser Gly Lys Tyr Lys Tyr Leu Lys Lys Ala Arg Lys Tyr His Arg 50 55 60 Lys Gly Tyr Lys Lys Tyr Tyr Gly Gly Gly Ser Ser 65 70 75 <210> 12 <211> 71 <212> PRT <213> Artificial Sequence <220> <223> Foot protein 5 (FP-5, Mytilus coruscus) <400> 12 Tyr Asp Asp Tyr Ser Asp Gly Tyr Tyr Pro Gly Ser Ala Tyr Asn Tyr 1 5 10 15 Pro Ser Gly Ser His Trp His Gly His Gly Tyr Lys Gly Lys Tyr Tyr 20 25 30 Gly Lys Gly Lys Lys Tyr Tyr Tyr Lys Phe Lys Arg Thr Gly Lys Tyr 35 40 45 Lys Tyr Leu Lys Lys Ala Arg Lys Tyr His Arg Lys Gly Tyr Lys Lys 50 55 60 His Tyr Gly Gly Ser Ser Ser 65 70 <210> 13 <211> 76 <212> PRT <213> Artificial Sequence <220> <223> mussel adhesive protein foot protein type5 from (Mytilus galloprovincialis) <400> 13 Ser Ser Glu Glu Tyr Lys Gly Gly Tyr Tyr Pro Gly Asn Thr Tyr His 1 5 10 15 Tyr His Ser Gly Gly Ser Tyr His Gly Ser Gly Tyr His Gly Gly Tyr 20 25 30 Lys Gly Lys Tyr Tyr Gly Lys Ala Lys Lys Tyr Tyr Tyr Lys Tyr Lys 35 40 45 Asn Ser Gly Lys Tyr Lys Tyr Leu Lys Lys Ala Arg Lys Tyr His Arg 50 55 60 Lys Gly Tyr Lys Lys Tyr Tyr Gly Gly Gly Ser Ser 65 70 75 <210> 14 <211> 99 <212> PRT <213> Artificial Sequence <220> <223> mussel adhesive protein foot protein type 6 <400> 14 Gly Gly Gly Asn Tyr Arg Gly Tyr Cys Ser Asn Lys Gly Cys Arg Ser 1 5 10 15 Gly Tyr Ile Phe Tyr Asp Asn Arg Gly Phe Cys Lys Tyr Gly Ser Ser 20 25 30 Ser Tyr Lys Tyr Asp Cys Gly Asn Tyr Ala Gly Cys Cys Leu Pro Arg 35 40 45 Asn Pro Tyr Gly Arg Val Lys Tyr Tyr Cys Thr Lys Lys Tyr Ser Cys 50 55 60 Pro Asp Asp Phe Tyr Tyr Tyr Asn Asn Lys Gly Tyr Tyr Tyr Tyr Asn 65 70 75 80 Asp Lys Asp Tyr Phe Asn Cys Gly Ser Tyr Asn Gly Cys Cys Leu Arg 85 90 95 Ser Gly Tyr <210> 15 <211> 194 <212> PRT <213> Artificial Sequence <220> <223> hybrid mussel adhesive protein (FP-151, MEFP-5 based) <400> 15 Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro 1 5 10 15 Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys 20 25 30 Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr 35 40 45 Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ser Ser Glu Glu 50 55 60 Tyr Lys Gly Gly Tyr Tyr Pro Gly Asn Ala Tyr His Tyr His Ser Gly 65 70 75 80 Gly Ser Tyr His Gly Ser Gly Tyr His Gly Gly Tyr Lys Gly Lys Tyr 85 90 95 Tyr Gly Lys Ala Lys Lys Tyr Tyr Tyr Lys Tyr Lys Asn Ser Gly Lys 100 105 110 Tyr Lys Tyr Leu Lys Lys Ala Arg Lys Tyr His Arg Lys Gly Tyr Lys 115 120 125 Tyr Tyr Gly Gly Ser Ser Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys 130 135 140 Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro 145 150 155 160 Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys 165 170 175 Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr 180 185 190 Tyr Lys <210> 16 <211> 196 <212> PRT <213> Artificial Sequence <220> <223> hybrid mussel adhesive protein (FP-151, MGFP-5 based) <400> 16 Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro 1 5 10 15 Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys 20 25 30 Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr 35 40 45 Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ser Ser Glu Glu 50 55 60 Tyr Lys Gly Gly Tyr Tyr Pro Gly Asn Thr Tyr His Tyr His Ser Gly 65 70 75 80 Gly Ser Tyr His Gly Ser Gly Tyr His Gly Gly Tyr Lys Gly Lys Tyr 85 90 95 Tyr Gly Lys Ala Lys Lys Tyr Tyr Tyr Lys Tyr Lys Asn Ser Gly Lys 100 105 110 Tyr Lys Tyr Leu Lys Lys Ala Arg Lys Tyr His Arg Lys Gly Tyr Lys 115 120 125 Lys Tyr Tyr Gly Gly Gly Ser Ser Ala Lys Pro Ser Tyr Pro Pro Thr 130 135 140 Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser 145 150 155 160 Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys 165 170 175 Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro 180 185 190 Pro Thr Tyr Lys 195 <210> 17 <211> 192 <212> PRT <213> Artificial Sequence <220> <223> hybrid mussel adhesive protein (FP-151, MCFP-5 based) <400> 17 Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro 1 5 10 15 Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys 20 25 30 Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr 35 40 45 Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Tyr Asp Gly Tyr 50 55 60 Ser Asp Gly Tyr Tyr Pro Gly Ser Ala Tyr Asn Tyr Pro Ser Gly Ser 65 70 75 80 His Gly Tyr His Gly His Gly Tyr Lys Gly Lys Tyr Tyr Gly Lys Gly 85 90 95 Lys Lys Tyr Tyr Tyr Lys Tyr Lys Arg Thr Gly Lys Tyr Lys Tyr Leu 100 105 110 Lys Lys Ala Arg Lys Tyr His Arg Lys Gly Tyr Lys Lys Tyr Tyr Gly 115 120 125 Gly Gly Ser Ser Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys 130 135 140 Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr 145 150 155 160 Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser 165 170 175 Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys 180 185 190 <210> 18 <211> 177 <212> PRT <213> Artificial Sequence <220> <223> hybrid mussel adhesive protein (FP-131) <400> 18 Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro 1 5 10 15 Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys 20 25 30 Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr 35 40 45 Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Gly Cys Arg Ala 50 55 60 Asp Tyr Tyr Gly Pro Lys Tyr Gly Pro Pro Arg Arg Tyr Gly Gly Gly 65 70 75 80 Asn Tyr Asn Arg Tyr Gly Gly Ser Arg Arg Tyr Gly Gly Tyr Lys Gly 85 90 95 Trp Asn Asn Gly Trp Lys Arg Gly Arg Trp Gly Arg Lys Tyr Tyr Glu 100 105 110 Phe Glu Phe Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro 115 120 125 Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr 130 135 140 Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr 145 150 155 160 Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Lys 165 170 175 Leu <210> 19 <211> 180 <212> PRT <213> Artificial Sequence <220> <223> hybrid mussel adhesive protein (FP-251) <400> 19 Met Glu Val His Ala Cys Lys Pro Asn Pro Cys Lys Asn Asn Gly Arg 1 5 10 15 Cys Tyr Pro Asp Gly Lys Thr Gly Tyr Lys Cys Lys Cys Val Gly Gly 20 25 30 Tyr Ser Gly Pro Thr Cys Ala Cys Ser Ser Glu Glu Tyr Lys Gly Gly 35 40 45 Tyr Tyr Pro Gly Asn Ser Asn His Tyr His Ser Gly Gly Ser Tyr His 50 55 60 Gly Ser Gly Tyr His Gly Gly Tyr Lys Gly Lys Tyr Tyr Gly Lys Ala 65 70 75 80 Lys Lys Tyr Tyr Tyr Lys Tyr Lys Asn Ser Gly Lys Tyr Lys Tyr Leu 85 90 95 Lys Lys Ala Arg Lys Tyr His Arg Lys Gly Tyr Lys Lys Tyr Tyr Gly 100 105 110 Gly Ser Ser Glu Phe Glu Phe Ala Lys Pro Ser Tyr Pro Pro Thr Tyr 115 120 125 Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr 130 135 140 Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala 145 150 155 160 Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro 165 170 175 Thr Tyr Lys Lys 180 <210> 20 <211> 16 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide <400> 20 Lys Leu Trp Lys Lys Trp Ala Lys Lys Trp Leu Lys Leu Trp Lys Ala 1 5 10 15 <210> 21 <211> 11 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide <400> 21 Phe Ala Leu Ala Leu Lys Ala Leu Lys Lys Leu 1 5 10 <210> 22 <211> 12 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide <400> 22 Ile Leu Arg Trp Pro Trp Trp Pro Trp Arg Arg Lys 1 5 10 <210> 23 <211> 12 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide <400> 23 Ala Lys Arg His His Gly Tyr Lys Arg Lys Phe His 1 5 10 <210> 24 <211> 15 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide <400> 24 Lys Trp Lys Leu Phe Lys Lys Ile Gly Ala Val Leu Lys Val Leu 1 5 10 15 <210> 25 <211> 15 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide <400> 25 Leu Val Lys Leu Val Ala Gly Ile Lys Lys Phe Leu Lys Trp Lys 1 5 10 15 <210> 26 <211> 25 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide <400> 26 Ile Trp Ser Ile Leu Ala Pro Leu Gly Thr Thr Leu Val Lys Leu Val 1 5 10 15 Ala Gly Ile Gly Gln Gln Lys Arg Lys 20 25 <210> 27 <211> 20 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide <400> 27 Gly Ile Gly Ala Val Leu Lys Val Leu Thr Thr Gly Leu Pro Ala Leu 1 5 10 15 Ile Ser Trp Ile 20 <210> 28 <211> 16 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide <400> 28 Ser Trp Leu Ser Lys Thr Ala Lys Lys Gly Ala Val Leu Lys Val Leu 1 5 10 15 <210> 29 <211> 11 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide <400> 29 Lys Lys Leu Phe Lys Lys Ile Leu Lys Tyr Leu 1 5 10 <210> 30 <211> 16 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide <400> 30 Gly Leu Lys Lys Leu Ile Ser Trp Ile Lys Arg Ala Ala Gln Gln Gly 1 5 10 15 <210> 31 <211> 39 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide <400> 31 Gly Trp Leu Lys Lys Ile Gly Lys Lys Ile Glu Arg Val Gly Gln His 1 5 10 15 Thr Arg Asp Ala Thr Ile Gln Gly Leu Gly Ile Ala Gln Gln Ala Ala 20 25 30 Asn Val Ala Ala Thr Ala Arg 35 <110> Kollodis Bioscience Co. Ltd. <120> Adhesive Protein Comprising Antimicrobial Peptide and Antimicrobial Coating Composition Comprising the Same <130> 2014-dpa-0823 <160> 31 <170> Kopatentin 2.0 <210> 1 <211> 10 <212> PRT <213> Artificial Sequence <220> <223> peptide peptide of the tandem repeat decapeptide derived from foot protein 1 (FP-1, Mytilus edulis) <400> 1 Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys 1 5 10 <210> 2 <211> 20 <212> PRT <213> Artificial Sequence <220> <223> 2 times repeated sequence derived from foot protein 1 (FP-1, Mytilus edulis) <400> 2 Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro 1 5 10 15 Pro Thr Tyr Lys 20 <210> 3 <211> 60 <212> PRT <213> Artificial Sequence <220> <223> 6 times repeated sequence derived from foot protein 1 (FP-1, Mytilus edulis) <400> 3 Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro 1 5 10 15 Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys 20 25 30 Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr 35 40 45 Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys 50 55 60 <210> 4 <211> 39 <212> PRT <213> Artificial Sequence <220> Partial sequence of foot protein type 2 (FP-2, Mytilus californianus) <400> 4 Glu Val His Ala Cys Lys Pro Asn Pro Cys Lys Asn Asn Gly Arg Cys 1 5 10 15 Tyr Pro Asp Gly Lys Thr Gly Tyr Lys Cys Lys Cys Val Gly Gly Tyr 20 25 30 Ser Gly Pro Thr Cys Ala Cys 35 <210> 5 <211> 52 <212> PRT <213> Artificial Sequence <220> Foot protein type 3 (FP-3, Mytilus edulis) <400> 5 Ala Asp Tyr Tyr Gly Pro Lys Tyr Gly Pro Pro Arg Arg Tyr Gly Gly 1 5 10 15 Gly Asn Tyr Asn Arg Tyr Gly Gly Ser Arg Arg Tyr Gly Gly Tyr Lys 20 25 30 Gly Trp Asn Asn Gly Trp Lys Arg Gly Arg Trp Gly Arg Lys Tyr Tyr 35 40 45 Glu Phe Glu Phe 50 <210> 6 <211> 46 <212> PRT <213> Artificial Sequence <220> Foot protein type 3 (FP-3, Mytilus galloprovincialis: mgfp-3A) <400> 6 Ala Asp Tyr Tyr Gly Pro Lys Tyr Gly Pro Pro Arg Arg Tyr Gly Gly 1 5 10 15 Gly Asn Tyr Asn Arg Tyr Gly Arg Arg Tyr Gly Gly Tyr Lys Gly Trp 20 25 30 Asn Asn Gly Trp Lys Arg Gly Arg Trp Gly Arg Lys Tyr Tyr 35 40 45 <210> 7 <211> 50 <212> PRT <213> Artificial Sequence <220> Foot protein type 3 (FP-3, Mytilus edulis: mefp-3F) <400> 7 Ala Asp Tyr Tyr Gly Pro Asn Tyr Gly Pro Pro Arg Arg Tyr Gly Gly 1 5 10 15 Gly Asn Tyr Asn Arg Tyr Asn Gly Tyr Gly Gly Gly Arg Arg Tyr Gly 20 25 30 Gly Tyr Lys Gly Trp Asn Asn Gly Trp Asn Arg Gly Arg Arg Gly Lys 35 40 45 Tyr Trp 50 <210> 8 <211> 44 <212> PRT <213> Artificial Sequence <220> Foot protein type 3 (FP-3, Mytilus californianus) <400> 8 Gly Ala Tyr Lys Gly Pro Asn Tyr Asn Tyr Pro Trp Arg Tyr Gly Gly 1 5 10 15 Lys Tyr Asn Gly Tyr Lys Gly Tyr Pro Arg Gly Tyr Gly Trp Asn Lys 20 25 30 Gly Trp Asn Lys Gly Arg Trp Gly Arg Lys Tyr Tyr 35 40 <210> 9 <211> 60 <212> PRT <213> Artificial Sequence <220> Partial sequence from foot protein type 4 (Mytilus californianus) <400> 9 Gly His Val His Arg His Arg Val Leu His Lys His Val His Asn His 1 5 10 15 Arg Val Leu His Lys His Leu His Lys His Gln Val Leu His Gly His 20 25 30 Val His Arg His Gln Val Leu His Lys His Val His Asn His Arg Val 35 40 45 Leu His Lys His Leu His Lys His Gln Val Leu His 50 55 60 <210> 10 <211> 75 <212> PRT <213> Artificial Sequence <220> Foot protein type 5 (FP-5, Mytilus edulis) <400> 10 Ser Ser Glu Glu Tyr Lys Gly Gly Tyr Tyr Pro Gly Asn Ala Tyr His 1 5 10 15 Tyr His Ser Gly Gly Ser Tyr His Gly Ser Gly Tyr His Gly Gly Tyr 20 25 30 Lys Gly Lys Tyr Tyr Gly Lys Ala Lys Lys Tyr Tyr Tyr Lys Tyr Lys 35 40 45 Asn Ser Gly Lys Tyr Lys Tyr Leu Lys Lys Ala Arg Lys Tyr His Arg 50 55 60 Lys Gly Tyr Lys Lys Tyr Tyr Gly Gly Ser Ser 65 70 75 <210> 11 <211> 76 <212> PRT <213> Artificial Sequence <220> ≪ 223 > Foot protein 5 (FP-5, Mytilus edulis) <400> 11 Ser Ser Glu Glu Tyr Lys Gly Gly Tyr Tyr Pro Gly Asn Thr Tyr His 1 5 10 15 Tyr His Ser Gly Gly Ser Tyr His Gly Ser Gly Tyr His Gly Gly Tyr 20 25 30 Lys Gly Lys Tyr Tyr Gly Lys Ala Lys Lys Tyr Tyr Tyr Lys Tyr Lys 35 40 45 Asn Ser Gly Lys Tyr Lys Tyr Leu Lys Lys Ala Arg Lys Tyr His Arg 50 55 60 Lys Gly Tyr Lys Lys Tyr Tyr Gly Gly Gly Ser Ser 65 70 75 <210> 12 <211> 71 <212> PRT <213> Artificial Sequence <220> ≪ 223 > Foot protein 5 (FP-5, Mytilus coruscus) <400> 12 Tyr Asp Asp Tyr Ser Asp Gly Tyr Tyr Pro Gly Ser Ala Tyr Asn Tyr 1 5 10 15 Pro Ser Gly Ser His Trp His Gly His Gly Tyr Lys Gly Lys Tyr Tyr 20 25 30 Gly Lys Gly Lys Lys Tyr Tyr Tyr Lys Phe Lys Arg Thr Gly Lys Tyr 35 40 45 Lys Tyr Leu Lys Lys Ala Arg Lys Tyr His Arg Lys Gly Tyr Lys Lys 50 55 60 His Tyr Gly Gly Ser Ser Ser 65 70 <210> 13 <211> 76 <212> PRT <213> Artificial Sequence <220> <223> mussel adhesive protein protein type 5 from (Mytilus galloprovincialis) <400> 13 Ser Ser Glu Glu Tyr Lys Gly Gly Tyr Tyr Pro Gly Asn Thr Tyr His 1 5 10 15 Tyr His Ser Gly Gly Ser Tyr His Gly Ser Gly Tyr His Gly Gly Tyr 20 25 30 Lys Gly Lys Tyr Tyr Gly Lys Ala Lys Lys Tyr Tyr Tyr Lys Tyr Lys 35 40 45 Asn Ser Gly Lys Tyr Lys Tyr Leu Lys Lys Ala Arg Lys Tyr His Arg 50 55 60 Lys Gly Tyr Lys Lys Tyr Tyr Gly Gly Gly Ser Ser 65 70 75 <210> 14 <211> 99 <212> PRT <213> Artificial Sequence <220> <223> mussel adhesive protein foot protein type 6 <400> 14 Gly Gly Asn Tyr Arg Gly Tyr Cys Ser Asn Lys Gly Cys Arg Ser 1 5 10 15 Gly Tyr Ile Phe Tyr Asp Asn Arg Gly Phe Cys Lys Tyr Gly Ser Ser 20 25 30 Ser Tyr Lys Tyr Asp Cys Gly Asn Tyr Ala Gly Cys Cys Leu Pro Arg 35 40 45 Asn Pro Tyr Gly Arg Val Lys Tyr Tyr Cys Thr Lys Lys Tyr Ser Cys 50 55 60 Pro Asp Phe Tyr Tyr Tyr Asn Asn Lys Gly Tyr Tyr Tyr Tyr Asn 65 70 75 80 Asp Lys Asp Tyr Phe Asn Cys Gly Ser Tyr Asn Gly Cys Cys Leu Arg 85 90 95 Ser Gly Tyr <210> 15 <211> 194 <212> PRT <213> Artificial Sequence <220> <223> hybrid mussel adhesive protein (FP-151, MEFP-5 based) <400> 15 Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro 1 5 10 15 Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys 20 25 30 Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr 35 40 45 Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ser Ser Glu Glu 50 55 60 Tyr Lys Gly Gly Tyr Tyr Pro Gly Asn Ala Tyr His Tyr His Ser Gly 65 70 75 80 Gly Ser Tyr His Gly Ser Gly Tyr His Gly Gly Tyr Lys Gly Lys Tyr 85 90 95 Tyr Gly Lys Ala Lys Lys Tyr Tyr Tyr Lys Tyr Lys Asn Ser Gly Lys 100 105 110 Tyr Lys Tyr Leu Lys Lys Ala Arg Lys Tyr His Arg Lys Gly Tyr Lys 115 120 125 Tyr Tyr Gly Gly Ser Ser Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys 130 135 140 Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro 145 150 155 160 Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys 165 170 175 Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr 180 185 190 Tyr Lys <210> 16 <211> 196 <212> PRT <213> Artificial Sequence <220> <223> hybrid mussel adhesive protein (FP-151, MGFP-5 based) <400> 16 Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro 1 5 10 15 Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys 20 25 30 Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr 35 40 45 Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ser Ser Glu Glu 50 55 60 Tyr Lys Gly Gly Tyr Tyr Pro Gly Asn Thr Tyr His Tyr His Ser Gly 65 70 75 80 Gly Ser Tyr His Gly Ser Gly Tyr His Gly Gly Tyr Lys Gly Lys Tyr 85 90 95 Tyr Gly Lys Ala Lys Lys Tyr Tyr Tyr Lys Tyr Lys Asn Ser Gly Lys 100 105 110 Tyr Lys Tyr Leu Lys Lys Ala Arg Lys Tyr His Arg Lys Gly Tyr Lys 115 120 125 Lys Tyr Tyr Gly Gly Gly Ser Ser Ala Lys Pro Ser Tyr Pro Pro Thr 130 135 140 Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser 145 150 155 160 Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys 165 170 175 Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro 180 185 190 Pro Thr Tyr Lys 195 <210> 17 <211> 192 <212> PRT <213> Artificial Sequence <220> <223> hybrid mussel adhesive protein (FP-151, MCFP-5 based) <400> 17 Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro 1 5 10 15 Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys 20 25 30 Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr 35 40 45 Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Tyr Asp Gly Tyr 50 55 60 Ser Asp Gly Tyr Tyr Pro Gly Ser Ser Ala Tyr Asn Tyr Ser Ser Ser Ser Ser 65 70 75 80 His Gly Tyr His Gly His Gly Tyr Lys Gly Lys Tyr Tyr Gly Lys Gly 85 90 95 Lys Lys Tyr Tyr Tyr Lys Tyr Lys Arg Thr Gly Lys Tyr Lys Tyr Leu 100 105 110 Lys Lys Ala Arg Lys Tyr His Arg Lys Gly Tyr Lys Lys Tyr Tyr Gly 115 120 125 Gly Gly Ser Ser Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys 130 135 140 Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr 145 150 155 160 Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser 165 170 175 Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys 180 185 190 <210> 18 <211> 177 <212> PRT <213> Artificial Sequence <220> <223> hybrid mussel adhesive protein (FP-131) <400> 18 Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro 1 5 10 15 Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys 20 25 30 Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr 35 40 45 Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Gly Cys Arg Ala 50 55 60 Asp Tyr Tyr Gly Pro Lys Tyr Gly Pro Pro Arg Arg Tyr Gly Gly Gly 65 70 75 80 Asn Tyr Asn Arg Tyr Gly Gly Ser Arg Arg Tyr Gly Gly Tyr Lys Gly 85 90 95 Trp Asn Asn Gly Trp Lys Arg Gly Arg Trp Gly Arg Lys Tyr Tyr Glu 100 105 110 Phe Glu Phe Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro 115 120 125 Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr 130 135 140 Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr 145 150 155 160 Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Lys 165 170 175 Leu <210> 19 <211> 180 <212> PRT <213> Artificial Sequence <220> <223> hybrid mussel adhesive protein (FP-251) <400> 19 Met Glu Val His Ala Cys Lys Pro Asn Pro Cys Lys Asn Asn Gly Arg 1 5 10 15 Cys Tyr Pro Asp Gly Lys Thr Gly Tyr Lys Cys Lys Cys Val Gly Gly 20 25 30 Tyr Ser Gly Pro Thr Cys Ala Cys Ser Ser Glu Glu Tyr Lys Gly Gly 35 40 45 Tyr Tyr Pro Gly Asn Ser Asn His Tyr His Ser Gly Gly Ser Tyr His 50 55 60 Gly Ser Gly Tyr His Gly Gly Tyr Lys Gly Lys Tyr Tyr Gly Lys Ala 65 70 75 80 Lys Lys Tyr Tyr Tyr Lys Tyr Lys Tyr Leu 85 90 95 Lys Lys Ala Arg Lys Tyr His Arg Lys Gly Tyr Lys Lys Tyr Tyr Gly 100 105 110 Gly Ser Ser Glu Phe Glu Phe Ala Lys Pro Ser Tyr Pro Pro Thr Tyr 115 120 125 Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr 130 135 140 Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala 145 150 155 160 Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro 165 170 175 Thr Tyr Lys Lys 180 <210> 20 <211> 16 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide <400> 20 Lys Leu Trp Lys Lys Trp Ala Lys Lys Trp Leu Lys Leu Trp Lys Ala 1 5 10 15 <210> 21 <211> 11 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide <400> 21 Phe Ala Leu Ala Leu Lys Ala Leu Lys Lys Leu 1 5 10 <210> 22 <211> 12 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide <400> 22 Ile Leu Arg Trp Pro Trp Trp Pro Trp Arg Arg Lys 1 5 10 <210> 23 <211> 12 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide <400> 23 Ala Lys Arg His His Gly Tyr Lys Arg Lys Phe His 1 5 10 <210> 24 <211> 15 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide <400> 24 Lys Trp Lys Leu Phe Lys Lys Ile Gly Ala Val Leu Lys Val Leu 1 5 10 15 <210> 25 <211> 15 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide <400> 25 Leu Val Lys Leu Val Ala Gly Ile Lys Lys Phe Leu Lys Trp Lys 1 5 10 15 <210> 26 <211> 25 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide <400> 26 Ile Trp Ser Ile Leu Ala Pro Leu Gly Thr Thr Leu Val Lys Leu Val 1 5 10 15 Ala Gly Ile Gly Gln Gln Lys Arg Lys 20 25 <210> 27 <211> 20 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide <400> 27 Gly Ile Gly Ala Val Leu Lys Val Leu Thr Thr Gly Leu Pro Ala Leu 1 5 10 15 Ile Ser Trp Ile 20 <210> 28 <211> 16 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide <400> 28 Ser Trp Leu Ser Lys Thr Ala Lys Lys Gly Ala Val Leu Lys Val Leu 1 5 10 15 <210> 29 <211> 11 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide <400> 29 Lys Lys Leu Phe Lys Lys Ile Leu Lys Tyr Leu 1 5 10 <210> 30 <211> 16 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide <400> 30 Gly Leu Lys Lys Leu Ile Ser Trp Ile Lys Arg Ala Gln Gln Gly 1 5 10 15 <210> 31 <211> 39 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide <400> 31 Gly Trp Leu Lys Lys Ile Gly Lys Lys Ile Glu Arg Val Gly Gln His 1 5 10 15 Thr Arg Asp Ala Thr Ile Gln Gly Leu Gly Ile Ala Gln Gln Ala Ala 20 25 30 Asn Val Ala Ala Thr Ala Arg 35
Claims (13)
상기 항균 코팅 조성물 내의 항균 접착 단백질의 농도는 0.01∼1% (wt/wt)인 항균 코팅 조성물.The method of claim 8,
Wherein the concentration of the antimicrobial adhesive protein in the antimicrobial coating composition is 0.01 to 1% (wt / wt).
수용성 아크릴레이트를 추가로 포함하는 항균 코팅 조성물.The method of claim 8,
The antimicrobial coating composition further comprising a water-soluble acrylate.
상기 수용성 아크릴레이트는 우레탄 아크릴레이트, 폴리에스테르 아크릴레이트 및 에폭시 아크릴레이트로 이루어진 군으로부터 선택되는 항균 코팅 조성물.The method of claim 10,
Wherein said water soluble acrylate is selected from the group consisting of urethane acrylate, polyester acrylate and epoxy acrylate.
상기 항균 필름은 식품 포장 또는 휴대폰의 액정 보호용으로 사용되는 항균 필름.The method of claim 12,
The antimicrobial film is used for food packaging or liquid crystal protection of mobile phones.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140072353A KR101652263B1 (en) | 2014-06-13 | 2014-06-13 | Adhesive Protein Comprising Antimicrobial Peptide and Antimicrobial Coating Composition Comprising the Same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140072353A KR101652263B1 (en) | 2014-06-13 | 2014-06-13 | Adhesive Protein Comprising Antimicrobial Peptide and Antimicrobial Coating Composition Comprising the Same |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20150143173A KR20150143173A (en) | 2015-12-23 |
KR101652263B1 true KR101652263B1 (en) | 2016-08-30 |
Family
ID=55082403
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020140072353A KR101652263B1 (en) | 2014-06-13 | 2014-06-13 | Adhesive Protein Comprising Antimicrobial Peptide and Antimicrobial Coating Composition Comprising the Same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101652263B1 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190004677A (en) | 2017-07-04 | 2019-01-14 | 주식회사 바이오빛 | Biocompatible Composition for Rapid Synthesis of Antimicrobial Cosmetic Puff and Method for Preparation thereof |
KR102218100B1 (en) * | 2020-08-12 | 2021-02-19 | 최준영 | Antibacterial film for food packaging |
KR20220043985A (en) | 2020-09-28 | 2022-04-06 | 주식회사 바이오빛 | Recombinant Polypeptide from Mussel Adhesive Protein and Use Thereof |
KR20220075535A (en) | 2020-11-30 | 2022-06-08 | 주식회사 바이오빛 | Composition for Inhibiting Inflammatory Disease Comprising Biocompatible Polypeptide Connected to Functional Peptide |
EP4156929A4 (en) * | 2020-05-27 | 2023-12-06 | Vacopak Industries Ltd. | Antimicrobial coating for food packaging |
WO2024005225A1 (en) * | 2022-06-29 | 2024-01-04 | 주식회사 바이오빛 | Filter coated with functional polypeptide |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102424889B1 (en) * | 2015-06-08 | 2022-07-25 | 콜로디스 바이오사이언스, 인코포레이티드 | Biofunctional Adhesive Composition |
KR102601138B1 (en) * | 2016-10-28 | 2023-11-10 | 주식회사 포스코 | Antibiotic bioadhesive film composition and antibiotic bioadhesive film prepared using the same |
CN106518999B (en) * | 2016-11-25 | 2018-08-28 | 东北农业大学 | Antibacterial peptide WW and its preparation method and application based on micro peptide strategy |
WO2018174307A1 (en) * | 2017-03-20 | 2018-09-27 | 콜로디스 바이오사이언스, 인코포레이티드 | Method for separating and purifying mussel adhesive protein |
WO2019017658A1 (en) * | 2017-07-18 | 2019-01-24 | 주식회사 포스코 | Antimicrobial adhesive protein, antimicrobial nanoparticle, antimicrobial composition comprising same nanoparticle, and preparation method for same composition |
WO2019112352A2 (en) * | 2017-12-06 | 2019-06-13 | 주식회사 아모라이프사이언스 | Method for producing mussel adhesive protein |
US20190224278A1 (en) * | 2018-01-22 | 2019-07-25 | Intelligent Synthetic Biology Center | Producing method of antimicrobial peptide with enhanced adhesion and uses thereof |
KR102138254B1 (en) * | 2018-01-22 | 2020-07-29 | 재단법인 지능형 바이오 시스템 설계 및 합성 연구단 | Producing method of antimicrobial peptide with enhanced adhesion and uses thereof |
KR102195156B1 (en) * | 2018-11-20 | 2020-12-28 | 주식회사 바이오빛 | Antimicrobial Adhesive Composition and Method For Preparing Same |
WO2022145518A1 (en) * | 2020-12-29 | 2022-07-07 | 주식회사 바이오빛 | Hard coating composition comprising antibacterial protein and method for preparing same |
CN114456250B (en) * | 2022-03-30 | 2023-12-26 | 成都英普博集生物科技有限公司 | Mussel-like mucin purification process |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100536551B1 (en) | 2002-01-31 | 2005-12-14 | (주)마이크로 사이언스 테크 | Monomer with anti-microbial character, polymer using the same, and manufacturing method thereof |
CN1989152A (en) * | 2004-03-26 | 2007-06-27 | Posco公司 | Mussel bioadhesive |
US20070048344A1 (en) | 2005-08-31 | 2007-03-01 | Ali Yahiaoui | Antimicrobial composition |
US20070166344A1 (en) | 2006-01-18 | 2007-07-19 | Xin Qu | Non-leaching surface-active film compositions for microbial adhesion prevention |
KR20090024467A (en) | 2007-09-04 | 2009-03-09 | 엘지전자 주식회사 | Control method of a laundry treatment machine |
KR101492169B1 (en) * | 2012-09-13 | 2015-02-10 | 포항공과대학교 산학협력단 | Electrospining nanofibers reinforced by mussel coating protein and their application |
-
2014
- 2014-06-13 KR KR1020140072353A patent/KR101652263B1/en active IP Right Grant
Non-Patent Citations (1)
Title |
---|
Shalev et al., J. Mater. Chem., 22:pp.2026-2032 (2011.12. 9.)* |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190004677A (en) | 2017-07-04 | 2019-01-14 | 주식회사 바이오빛 | Biocompatible Composition for Rapid Synthesis of Antimicrobial Cosmetic Puff and Method for Preparation thereof |
EP4156929A4 (en) * | 2020-05-27 | 2023-12-06 | Vacopak Industries Ltd. | Antimicrobial coating for food packaging |
KR102218100B1 (en) * | 2020-08-12 | 2021-02-19 | 최준영 | Antibacterial film for food packaging |
KR20220043985A (en) | 2020-09-28 | 2022-04-06 | 주식회사 바이오빛 | Recombinant Polypeptide from Mussel Adhesive Protein and Use Thereof |
KR20230110455A (en) | 2020-09-28 | 2023-07-24 | 주식회사 바이오빛 | Recombinant Polypeptide from Mussel Adhesive Protein and Use Thereof |
KR20220075535A (en) | 2020-11-30 | 2022-06-08 | 주식회사 바이오빛 | Composition for Inhibiting Inflammatory Disease Comprising Biocompatible Polypeptide Connected to Functional Peptide |
WO2024005225A1 (en) * | 2022-06-29 | 2024-01-04 | 주식회사 바이오빛 | Filter coated with functional polypeptide |
Also Published As
Publication number | Publication date |
---|---|
KR20150143173A (en) | 2015-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101652263B1 (en) | Adhesive Protein Comprising Antimicrobial Peptide and Antimicrobial Coating Composition Comprising the Same | |
KR102424889B1 (en) | Biofunctional Adhesive Composition | |
Guo et al. | Recent progress in synthesis and application of mussel-inspired adhesives | |
KR102571770B1 (en) | Functional coating composition and fabric using the same | |
Lutz et al. | Bio-based and bio-inspired adhesives from animals and plants for biomedical applications | |
Brubaker et al. | The present and future of biologically inspired adhesive interfaces and materials | |
Jeon et al. | Rapidly light-activated surgical protein glue inspired by mussel adhesion and insect structural crosslinking | |
KR101950009B1 (en) | Biocompatible Composition for Rapid Synthesis of Antimicrobial Cosmetic Puff and Method for Preparation thereof | |
Sun et al. | The overview of antimicrobial peptide‐coated implants against oral bacterial infections | |
WO2015126480A2 (en) | Self-assembling underwater adhesives | |
US8524861B2 (en) | Treatment of bacterial infections | |
Li et al. | Ternary complex coacervate of PEG/TA/gelatin as reinforced bioadhesive for skin wound repair | |
Bilotto et al. | Adhesive properties of adsorbed layers of two recombinant mussel foot proteins with different levels of DOPA and tyrosine | |
WO2020041557A1 (en) | Protein-based adhesive and its modification | |
Xu et al. | Advance in barnacle cement with high underwater adhesion | |
Hollingshead et al. | Effect of cross-linkers on mussel-and elastin-inspired adhesives on physiological substrates | |
WO2007105190A9 (en) | Amyloid and amyloid-like structures | |
US20170015885A1 (en) | Protein-based adhesives | |
CN110169950A (en) | A kind of syringeability antibacterial peptide hydrogel and preparation method thereof | |
TWI403330B (en) | Low hemolysis antibacterial peptide pharmaceutical compositions and use thereof | |
KR101610870B1 (en) | Surface-independent antibacterial coating bioadhesive | |
Schmidt et al. | Underwater Bonding with a Biobased Adhesive from Tannic Acid and Zein Protein | |
CN108753183A (en) | A kind of live body underwater adhesive material and application thereof | |
WO2001043143A1 (en) | Radioprotective materials and utilization thereof | |
Gim et al. | Production of fusion mussel adhesive fp‐353 in Escherichia coli |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |